SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001206774-21-002185
Filing Date
2021-08-16
Accepted
2021-08-16 16:20:40
Documents
14
Period of Report
2021-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron3944641-8k.htm   iXBRL 8-K 27143
2 PRESS RELEASE DATED AUGUST 16, 2021 geron3944641-ex991.htm EX-99.1 63584
6 GRAPHIC geron3944641-ex991x1x1.jpg GRAPHIC 4130
  Complete submission text file 0001206774-21-002185.txt   281949

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gern-20210816.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20210816_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20210816_pre.xml EX-101.PRE 22352
7 EXTRACTED XBRL INSTANCE DOCUMENT geron3944641-8k_htm.xml XML 3596
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 211178555
SIC: 2834 Pharmaceutical Preparations